ML

(redirected from mucolipidosis)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

ML

The two-character ISO 3166 country code for MALI.

ML

1. See Merrill Lynch and Co.

2. ISO 3166-1 alpha-2 code for the Republic of Mali. This is the code used in international transactions to and from Malian bank accounts.

3. ISO 3166-2 geocode for Mali. This is used as an international standard for shipping to Mali. Each Malian region has its own code with the prefix "ML" and a number following. For example, the code for the Region of Gao is ISO 3166-2:ML-7. The city of Bamako has its own lettered designation: ISO 3166-2:ML-BKO.
References in periodicals archive ?
1,4,11,12) Mucolipidosis type II [alpha]/[beta] and ML III [alpha]/[beta], the principal focus of the current report, are the result of mutations in the gene coding for the [alpha]/[beta] subunit where the catalytic domain resides.
Edelmann L, Dong J, Desnick RJ, Kornreich R Carrier screening for mucolipidosis type IV in the American Ashkenazi Jewish population.
Mucolipidosis II: This syndrome, also known as i cell disease, is characterized by short stature, coarse facial features, psychomotor retardation and gingival enlargement.
30) Mucolipidosis II/III 5/4 (a) P, patients; C, carriers; NA, not available.
The acid [alpha]-glucosidase protein was increased in individuals with acid lipase deficiency, mucolipidosis II/III, Gaucher disease, and Niemann-Pick disease (type A/B).
SE Cedar Rapids, IA 52403 (800) 261-6692 2,3 MUCOLIPIDOSES See: Mucopolysaccharidosis; Mucolipidosis Type IV; Tay-Sachs Disease MUCOLIPIDOSIS TYPE IV See also: Mucopolysaccharidosis; Tay-Sachs Disease; Visual Impairments ML4 Foundation 719 East 17th St.
It is worth noting that 13 of the LSD plasma samples were from newborns (<6 weeks of age), representing Gaucher (n = 3), Krabbe (n = 1), MLD (n = 2), MPS VI (n = 2), mucolipidosis II/III (n = 1), Niemann-Pick C (n = 2), Pompe (n = 1), and Tay-Sachs (n = 1) disorders.
However, this assay, like others for increased lysosomal enzymes in serum, cannot distinguish between mucolipidosis II and mucolipidosis III, which usually must be differentiated on the basis of events seen in clinical progression.
At 5:03 PM, August 16, 1990, my husband, David, phoned to tell me ' that our son, Scott, had a rare metaboric disease called Mucolipidosis Type IV or ML4.